KKR Leads $220M Growth Investment in Premialab

KKR Invests in Precipart to Accelerate Growth

October 24, 2023

Manufacturing

KKR has agreed to invest in Precipart, a Swiss contract manufacturer of precision components for the medical device, aerospace and industrial markets. The Laubscher family will retain a significant minority stake; KKR is investing through its Health Care Strategic Growth Fund II to support Precipart's organic growth and M&A-driven expansion. Financial terms were not disclosed.

Primus Capital Leads $40M Series B in PurpleLab

July 27, 2022

Data & Analytics

Primus Capital led a $40 million Series B investment in PurpleLab, Inc., joining existing investor Edison Partners to fund the health‑tech company's growth. The capital will accelerate development of PurpleLab's HealthNexus real‑world data platform, expand data assets, and support hiring and commercial expansion across life‑sciences, payers and providers.

THL and Premier Lead $50M Growth Investment in Qventus

February 28, 2022

AI & Machine Learning

Qventus announced a $50 million growth capital round led by Thomas H. Lee Partners with a strategic partnership and investment from Premier, Inc.; ThedaCare and existing investors Bessemer Venture Partners, Mayfield, and Norwest Venture Partners also participated. The funding and partnership will help Qventus expand its AI-powered care-operations platform across additional hospitals and health systems and enable product enhancements that leverage Premier’s data assets.

BlackRock to Acquire Preqin

June 30, 2024

Data & Analytics

BlackRock has agreed to acquire Preqin, a leading private markets data and research provider, for £2.55 billion (approximately $3.2 billion) in cash. The deal brings Preqin's data and recurring-revenue business into BlackRock's Aladdin platform to expand the firm's private markets data, analytics and technology capabilities and broaden its institutional client reach.

Align Capital Partners Recapitalizes Premier Biotech

December 7, 2022

Medical Devices

Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.

Summit Partners Invests $30M Growth Capital in PriceLabs

July 28, 2022

Cloud & SaaS

PriceLabs received a $30 million minority growth investment from Summit Partners to accelerate product development and global team expansion for its dynamic pricing and revenue management SaaS for the short-term rental industry. The funding will support continued hiring and product enhancements as PriceLabs scales its platform, which serves hundreds of thousands of listings worldwide; Summit Partners' Colin Mistele joined PriceLabs' board.